abiraterone stada
stada arzneimittel ag - abiraterono acetatas - plėvele dengtos tabletės - 250 mg - abiraterone
abiraterone stada
stada arzneimittel ag - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatos navikai, kastracija-atsparus - antinavikiniai vaistai - treatment of adult patients with prostate cancer.
xtandi
astellas pharma europe b.v. - enzalutamidas - prostatos navikai - endokrininė terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
citalopram actavis
actavis group ptc ehf. - citalopramas - plėvele dengtos tabletės - 20 mg; 10 mg; 40 mg - citalopram
citalopram-teva
teva pharma b.v. - citalopramas - plėvele dengtos tabletės - 20 mg; 40 mg - citalopram
pram
g.l. pharma gmbh - citalopramas - plėvele dengtos tabletės - 40 mg; 10 mg; 20 mg - citalopram
ketoconazole hra
hra pharma rare diseases - ketokonazolo - cushingo sindromas - antimycotics sisteminiam vartojimui - ketokonazolo hra skiriamas endogeninio cushingo sindromo gydymui suaugusiems ir paaugliams, vyresniems nei 12 metų.
numient
amneal pharma europe ltd - levodopa, carbidopa - parkinsono liga - anti-parkinsono vaistai - suaugusiųjų parkinsono ligos simptominis gydymas.
tybost
gilead sciences ireland uc - cobicistat - Živ infekcijos - antivirusiniai vaistai sisteminiam naudojimui - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.